Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
27 sept. 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Global Patient Centric Healthcare App Market Report 2022: Featuring Allscripts, Bayer, Boston Scientific, Pfizer, Siemens Healthineers & Others
23 sept. 2022 06h48 HE
|
Research and Markets
Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Patient Centric Healthcare App Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Achieve Life Sciences Announces Participation at Fall Investor Conferences
07 sept. 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update
11 août 2022 16h05 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022
28 juil. 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, July 28, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Global Smoking Cessation and Nicotine De-Addiction Products Market to 2028 - Industry Analysis, Trends, Market Size and Forecasts
19 juil. 2022 06h23 HE
|
Research and Markets
Dublin, July 19, 2022 (GLOBE NEWSWIRE) -- The "Smoking Cessation and Nicotine De-Addiction Products Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been...
Smoking Cessation and Nicotine De-Addiction Market to Reach US$ 27.84 Bn by 2031: TMR Study
18 juil. 2022 12h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 18, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Analysis of smoking cessation industry statistics over the past few decades has found that...
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
01 juil. 2022 16h05 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation
29 juin 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
21 juin 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...